March 15, 2010 Issue | Chemical & Engineering News
 
 
 
Copyright © 2010 American Chemical Society
 

March 15, 2010 Issue

Volume 88, Issue 11
8811cover1_facility2ac_opt
March 15, 2010 Issue, Vol. 88 | Iss. 11
Relationships between drug companies and chemistry outsourcing partners can span years, even decades
By Michael McCoy
(p.15)
Features
Business
North American producers are bracing for long-anticipated capacity to come on-line in the Middle East and Asia (pp. 30-33)
Science & Technology
Enhancing the aroma of food might help dieters eat less (pp. 51-52)
Back Issues
 

Cover Story: Pharma Outsourcing

Patently Right Process Chemistry
Case Study #1: Cytokinetics turns to Irix for help with a tough synthesis
(pp. 16-19)
Loyal Steward Of A Small Molecule
Case Study #2: For over 25 years, Regis has 
supplied 4-aminopyridine to successive 
stakeholders for a new multiple sclerosis drug
(pp. 21-23)
More Than A Supplier
Case Study #3: BioVectra seeks greater returns by partnering with Taxolog and Sandoz on a generic cancer drug
(pp. 25-27)
 

News of the Week

Unraveling Thalidomide's Tragic Effects

Cell Biology: Researchers discover a protein involved in causing birth defects related to the drug
(p.9)

Back Together In Business

Animal Health: Merck and Sanofi re-form a joint venture
(p.10)

Chemistry Over Colorado

Chlorine Surprise: Reactions may process up to one-fifth of inland nitrogen oxide emissions
(p.10)

European Chemicals Agency Proposes Expanded Regulations

Chemical Controls: Trichloroethylene and seven other compounds targeted
(p.11)

New Chains For Ionic Liquids

Molecular Design: Kinked fatty acid side chains create a new class of low-melting-point salts
(p.11)

Advancing Biomaterials

Cost Reduction: Chemical firms target alternative fuels and feedstocks
(p.12)

Exelixis Restructures

Biotech: Cancer drug firm shifts resources to development and cuts 40% of jobs
(p.12)

Abbott Takes On Facet

Big pharma firm wins bid for a promising pipeline of multiple sclerosis, oncology drugs
(p.13)

Climate-Change Panel Under Scrutiny

Inquiry: Science academies will assess UN's prestigious body
(p.13)
 

Departments

8811bus1_diet

Business

North American producers are bracing for long-anticipated capacity to come on-line in the Middle East and Asia
(pp. 30-33)
Biotech hub in Paris that keeps a science legacy alive now needs to expand
(pp. 35-36)
Cipla gears up for commercial production, joining other local players
(pp. 38-39)
Case Study #1: Cytokinetics turns to Irix for help with a tough synthesis
(pp. 16-19)
Case Study #2: For over 25 years, Regis has 
supplied 4-aminopyridine to successive 
stakeholders for a new multiple sclerosis drug
(pp. 21-23)
Case Study #3: BioVectra seeks greater returns by partnering with Taxolog and Sandoz on a generic cancer drug
(pp. 25-27)
Relationships between drug companies and chemistry outsourcing partners can span years, even decades
(p.15)
8811gov1_Ares

Government & Policy

But many in Congress are raising serious questions about the agency's human space exploration plans
(pp. 42-43)
National science board recommends ways to fend off challenges from global competitors
(pp. 44-46)
8811NOTW_p10colorado

Science & Technology

Chemical Ecology: Beewolf digger wasps use bacterial antibiotics to protect the next generation
(p.54)
Heat and a magnetic field lead liquid lithium to swirl on its own, like a whirlpool
(p.48)
Enhancing the aroma of food might help dieters eat less
(pp. 51-52)

Career & Employment

With biotech struggling to recover, many chemists remain out of work in California
(pp. 61-63)

Editor's Page